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Abstract.
Background: Occipital strokes often cause permanent homonymous hemianopia leading to significant disability. In previous
studies, non-invasive electrical brain stimulation (NIBS) has improved vision after optic nerve damage and in combination
with training after stroke.
Objective: We explored different NIBS modalities for rehabilitation of hemianopia after chronic stroke.
Methods: In a randomized, double-blinded, sham-controlled, three-armed trial, altogether 56 patients with homonymous
hemianopia were recruited. The three experiments were: i) repetitive transorbital alternating current stimulation (rtACS, n = 8)
vs. rtACS with prior cathodal transcranial direct current stimulation over the intact visual cortex (tDCS/rtACS, n = 8) vs. sham
(n = 8); ii) rtACS (n = 9) vs. sham (n = 9); and iii) tDCS of the visual cortex (n = 7) vs. sham (n = 7). Visual functions were
evaluated before and after the intervention, and after eight weeks follow-up. The primary outcome was change in visual field
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Results: Primary outcomes in Experiments 1 and 2 were negative. Only significant between-group change was observed in
Experiment 3, where tDCS increased visual field of the contralesional eye compared to sham. tDCS/rtACS improved dynamic
vision, reading, and visual field of the contralesional eye, but was not superior to other groups. rtACS alone increased foveal
sensitivity, but was otherwise ineffective. All trial-related procedures were tolerated well.
Conclusions: This exploratory trial showed safety but no main effect of NIBS on vision restoration after stroke. However, tDCS
and combined tDCS/rtACS induced improvements in visually guided performance that need to be confirmed in larger-sample
trials.
NCT01418820 (clinicaltrials.gov)
Keywords: Electrical stimulation, homonymous hemianopia, randomized controlled trial, rehabilitation, occipital stroke,
vision restoration
1. Introduction
Homonymous hemianopia is a binocular visual
hemifield loss that results from unilateral damage to
the central visual pathways, most commonly caused
by stroke (Zhang et al., 2006). Visual field defects
(VFD) affect around 30 to 50% of stroke patients (Ali
et al., 2013; Rowe et al., 2019), hindering activities
of daily living, such as reading, mobility, and driving
(Gall et al., 2010). Some patients recover either spon-
taneously (Gray et al., 1989; Tiel & Kolmel, 1991) or
after recanalization treatments (Strbian et al., 2012),
but recovery beyond the first six months is rare (Ali et
al., 2013; Zhang et al., 2006). Moreover, the evidence
on the efficacy of vision training after stroke from
few randomized clinical trials is limited (Pollock et
al., 2019).
Many groups have explored various non-invasive
brain stimulation (NIBS) modalities to improve low
vision, including transcranial direct current stimu-
lation (tDCS) and repetitive transorbital alternating
current stimulation (rtACS) (Sabel et al., 2020).
While the physiological NIBS effects on the visual
system are insufficiently understood, tDCS and ACS
are believed to act by different mechanisms. When
delivered at specific frequency bands, ACS can either
entrain or disrupt the underlying electrophysiolog-
ical activity, which modulates the phase coherence
of brain oscillations both locally and in anatomically
distinct, but functionally connected neuronal assem-
blies (Bola et al., 2014; Kanai et al., 2008; Zaehle et
al., 2010). By setting appropriate stimulation param-
eters, this can induce a partial restoration of network
connectivity by influencing the firing coherence of
the belonging nodes (neuronal assemblies) (Bola et
al., 2014; Ozen et al., 2010). In patients with optic
nerve damage, rtACS has improved visual detection
ability and shortened reaction time in a visuo-motor
paradigm, which correlated with increased coherence
in the electroencephalogram (EEG) alpha frequency
band of the brain functional connectivity network
(Bola et al., 2014; Gall et al., 2016).
tDCS in combination with visual training has
reduced VFD in subacute (Alber et al., 2017) and
chronic brain injury in small pilot studies (Halko et
al., 2011; Matteo et al., 2017; Plow et al., 2011; Plow
et al., 2012), though not all studies have produced
positive results (Larcombe et al., 2018). tDCS mod-
ulates neuronal excitability in a polarity-dependent
way: anodal stimulation excites neuronal assem-
blies by depolarization, whereas cathodal stimulation
causes inhibition by hyperpolarization (Nitsche et
al., 2008). After brain damage, the intact hemi-
sphere becomes hyperactive because of the loss of
mutual inhibition from the damaged hemisphere and
therefore down-modulates the excitability of the dam-
aged side (Rossini et al., 2003). Hence, reducing the
excitability of the intact hemisphere with cathodal
tDCS might disinhibit the lesioned side, while the
anodal tDCS over the damaged cortex increases its
excitability.
Based on the above reasoning, we designed a
new protocol applying cathodal tDCS over the intact
occipital cortex prior to rtACS. We hypothesized that
the combined tDCS/rtACS would be more effective
than rtACS alone, because reducing the transcal-
losal inhibition with tDCS over the intact hemisphere
might enhance the effect of rtACS.
We carried out a prospective, randomized, double-
blinded, exploratory multicenter REVIS trial (“Res-
toration of Vision after Stroke”) to investigate the
safety and efficacy of three different NIBS modalities
in rehabilitation of chronic occipital stroke patients
with persisting homonymous hemianopia. Our aim
was to find the most promising stimulation modal-
ity for further refinements and future developments.
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Hence, the trial was based on three experimental
arms: 1) rtACS vs. rtACS preceded by cathodal
tDCS vs. sham, 2) rtACS vs. sham, and 3) combined
anodal/cathodal tDCS vs. sham.
2. Methods
2.1. Study design
This randomized, controlled trial was run at three
centers: Magdeburg (Germany), Helsinki (Finland),
and Rome (Italy) between June 2012 and May 2016
(clinicaltrials.gov NCT01418820). The study proto-
col has been previously published (Gall et al., 2015).
The study was approved by the local ethics commit-
tees at all three centers: University of Magdeburg,
Medical Faculty (No. 173/13), the Ethics Commit-
tee of Helsinki and Uusimaa Hospital District (No.
49/13/03/01/13, date 13/03/2013), and the Ethics
Committee of the University Policlinic of Catholic
University in Rome (No. 4/2013, date 20/05/2013).
All participants gave their written informed consent
prior to the intervention.
2.2. Subjects
Subjects were screened from medical databases
of stroke patients treated in the recruiting centers.
Screening comprised an interview and neurological
and ophthalmological examinations, including near
visual acuity, refraction, high-resolution perimetry
(HRP), and static automated perimetry (SAP). All
subjects had undergone either brain magnetic reso-
nance imaging or computed tomography.
Inclusion criteria comprised (1) homonymous
hemianopia due to ischemic or hemorrhagic stroke,
(2) age between 18 and 75 years, (3) lesion age > 6
months, (4) stable VFD across baseline measure-
ments, (5) presence of residual vision i.e. detectable
gradual transition between the intact and the abso-
lutely blind part of the visual field according to the
evaluation of the clinician, and (6) best corrected
visual acuity ≥ 0.4 (20/50 Snellen).
Exclusion criteria were (1) known active malig-
nancy, (2) ophthalmological or neurological disease
that might interfere with the study, (3) electronic
implants, (4) intracranial or intraorbital metal arti-
facts, (5) expected low compliance (e.g. dementia),
(6) epileptic seizure within 10 years, and (7) use of
antiepileptic or sedative drugs.
2.3. Randomization
In Experiments 1 and 3, randomization was per-
formed with “Randomization In Treatment Arms”
software (RITA, StatSol, Lübeck, Germany). The
stratification considered the severity of the VFD at
baseline as a potential prognostic factor in blocked
randomization. In Experiment 2, blocked randomiza-
tion without stratification was used. Treatment codes
were provided to the therapist who applied the stim-
ulation, but the subjects and diagnostic staff were
blinded to the subjects´ group allocation.
Originally 57 subjects were randomized, but one
was excluded from the Experiment 2 before treat-
ment due to a late-appearing exclusion criterion. The
resulting sample sizes in three experiments were
(Fig. 1):
Experiment 1 (Magdeburg): i) sham-tDCS/active
rtACS, n = 8, ii) active tDCS/active rtACS, n = 8,
iii) sham-tDCS/sham-rtACS (n = 8);
Experiment 2 (Helsinki): i) rtACS (n = 9), ii) sham
(n = 9);
Experiment 3 (Rome): i) tDCS (n = 7), ii) sham
(n = 7).
2.4. Outcome measures
Diagnostic evaluations were carried out at three
time points: a baseline assessment prior to the inter-
vention, a post-treatment assessment two to five days
after the intervention, and a follow-up assessment at
eight weeks (Fig. 1). Examinations included SAP,
HRP, visual acuity, and reading performance in all
centers. Additionally, contrast sensitivity was per-
formed in Experiments 1 and 3 and dynamic visual
acuity (DVA) in Experiment 1.
The primary outcome was change in VFD deter-
mined with monocular SAP and binocular computer-
based HRP (Kasten et al., 1998). The former
measures near-threshold light detection in the 30◦
visual field, whereas the latter assesses super-
threshold visual detection of 12◦ central vision. In
HRP, visual field change was defined by a percent-
age of correctly-detected stimuli (detection accuracy,
DA) and in SAP by mean stimulus detection sensi-
tivity (MS), comparing baseline with post treatment
and follow-up. Secondary outcomes included addi-
tional variables derived from HRP, SAP, and other
functional visual tests.
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Fig. 1. Flowchart of the study. ACS, alternating current stimulation; DCS/ACS, combined direct current stimulation/alternating current
stimulation; DCS, direct current stimulation; HRP, high-resolution perimetry; DVA, dynamic visual acuity.
2.4.1. Static automated perimetry
Static monocular visual field perimetry was ob-
tained with a near-threshold Static Automated Peri-
metry (Oculus Twinfield, Lynnwood, WA in Exper-
iment 1, Octopus 900, Haag-Streit Diagnostics in
Experiment 2, and Humphrey Feld Analyzer II-i 750i
in Experiment 3). We determined threshold values at
59–76 positions of the 30◦ visual field, where target
stimuli (size: III/4 mm2, color: white, duration: 0.2 s)
were presented on a background with constant lumi-
nance of 10 cd/m2. MS of all test positions and foveal
sensitivity were analyzed. Additionally, in Experi-
ment 1, the sizes of the absolute and relative defect
and the intact field were defined as the fraction of test
positions detected at none, some, and all of the test
times during a session.
2.4.2. High resolution perimetry
In the computer-based HRP, static supra-threshold
white dots lasting 150 ms were presented in a
randomized sequence at 400 positions of a 21×21
grid on a dark screen; the location and number of cor-
rectly detected stimuli were registered as described
previously (Kasten et al., 1998). Each patient
performed three binocular tests that were superim-
posed to define intact, relative defect, and absolute
defect areas of the visual field. Detection accuracy,
reaction times, and false positive responses were
recorded.
2.4.3. Fixation control
To rule out that eye movements influenced HRP
results, fixation was monitored with an online eye
tracker (Tobii X2-60 Eye Tracker, Tobii Technology
AB, Sweden) in Experiments 1 and 2. Test points
during which a subject’s gaze deviated outside the
predefined area of 2◦ were disregarded and repeated
at the end of the test round. After three consecu-
tive failures, the test was paused, and the subject
was encouraged to maintain fixation. Calibration was
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Fig. 2. Results of primary outcomes in Experiments 1, 2, and 3. Median changes from baseline, 95%-CIs, and between-group p values,
calculated with Mann-Whitney U test or Kruskal-Wallis analysis of variance test in case of more than two groups, are given. ACS, alternating
current stimulation; DCS/ACS, combined direct current stimulation/alternating current stimulation; DCS, direct current stimulation; DA,
detection accuracy; MS, mean sensitivity; ILE, ipsilesional eye; CLE, contralesional eye. ∗Sham vs. ACS, calculated from post hoc pairwise
comparison.
run to achieve a mean fixation error < 1◦. In Exper-
iment 3, the subjects underwent microperimetry to
ensure sufficient fixation. Additionally, in all exper-
imental arms, during 10% of the trials, the fixation
point changed color isoluminantly to which subjects
had to react; the response rate was considered a surro-
gate of fixation accuracy. In SAP, fixation monitoring
depended on the perimetry used; it included either
automatic fixation control or manual control with
recorded fixation losses, and visual monitoring by a
researcher performing the measurement.
2.4.4. Functional visual tests
Other measures of visual function included near
visual acuity (Oculus® in Experiment 1 and 2
and MNREAD acuity chart in Experiment 3) and
reading performance. Reading was examined with
international reading speed test (IResT) (Trauzettel-
Klosinski & Dietz, 2012), validated for German,
Finnish, and Italian languages. The MARS contrast
sensitivity test (Dougherty et al., 2005) and computer-
assisted DVA test (Wist et al., 1998) were assessed in
a subset of experiments as described above.
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2.5. Non-invasive electrical stimulation
protocols
The treatment comprised 10 NIBS sessions with
20–40 min daily stimulation within a two-week
period (weekends off). NIBS was delivered with a
battery-driven stimulator (MC4, NeuroConn GmbH,
Ilmenau, Germany) through conductive-rubber elec-
trodes in saline-soaked sponges, while impedance
was kept < 10 kilo-ohm. During the stimulation, sub-
jects sat in a darkened room with their eyes closed.
The detailed stimulation parameters for each experi-
ment are described below.
2.5.1. Experiment 1
rtACS: The stimulation electrode (5×7 cm) was
placed at Fpz according to 10–20-EEG system and
the reference electrode (10×10 cm) on the right upper
arm. The stimulation was delivered for 20 min daily
with the current amplitude of 1.5 mA, clearly above
the phosphene threshold, i.e. flickering light sensation
for all subjects. Stimulation frequencies gradually
increased from 5 to 30 Hz in a 48 s “block” that were
repeated until the stimulation time was reached.
tDCS/rtACS: Cathodal tDCS was applied on the
intact hemisphere for 10 min immediately prior to
rtACS to “prime” the damaged hemisphere for the
rtACS effect. The stimulation intensity was 1 mA
for all participants via one electrode placed at either
the O1 or O2 position (3×3 cm), depending on the
side of the lesion. The anode was positioned at Fpz
(5×7 cm). rtACS followed the protocol described
above.
Sham: The rtACS-sham condition comprised occa-
sional current bursts (one 5 Hz burst every 1 min) at
100% of the phosphene threshold that induced weak
phosphenes to ensure blinding (Gall et al., 2016). In
the tDCS-sham condition, current was ramped up
for 30 s, then stopped, and at the end of the ses-
sion ramped down for another 30 s, which enabled
eliciting few cutaneous sensations.
2.5.2. Experiment 2
rtACS: The two stimulating electrodes (3×3 cm)
were placed on the forehead at Fp1 and Fp2, while
the reference electrode (5×7 cm) was positioned
on the right forearm. The stimulation was deliv-
ered for 30 min during treatment days 1–5 and for
40 min during days 6–10. Stimulation was delivered
sequentially at each stimulation electrode with fre-
quencies gradually increasing from 5 to 15 Hz in a
48-s “block”. The current amplitude was individually
adjusted to be at 100–150% of phosphene threshold
(0.45–1.5 mA peak-to-peak), which was defined at
the beginning of every stimulation session.
Sham: The sham condition comprised occasional
current bursts of ten pulses (one 5-Hz burst every 5
min) at 100% of the phosphene threshold to induce
weak phosphenes to ensure blinding.
2.5.3. Experiment 3
tDCS: tDCS was delivered as bilateral, dual-mode
stimulation over the visual cortex. Two stimulating
electrodes (5×5 cm) were at O1 and O2 positions: the
stimulating anodal electrode over the injured occip-
ital lobe and the stimulating cathodal electrode over
the intact hemisphere. Their respective cathodal and
anodal pairs (5×5 cm) were placed at Fp1 and Fp2.
tDCS was delivered with fixed 2-mA amplitude for
20 min daily (30-s fade-in).
Sham: The sham condition was identical to the one
in Experiment 1.
2.6. Statistical analyses
Statistical analyses were executed with SPSS Sta-
tistic 25 (IBM Corporation, Armonk, NY, USA). Nor-
mality of the data was evaluated with Shapiro-Wilk
and Kolmogorov-Smirnov tests. Given the small sam-
ple size and non-normal distribution of continuous
variables, we report their medians and interquartile
ranges (IQR) and used non-parametric methods for
analyses. Significance was two-sided p < 0.05 (trends
at p < 0.10).
The different treatment arms were compared
within each experiment. The absolute changes of out-
come variables between post treatment and baseline,
and follow-up and baseline were compared between
the groups with either Mann-Whitney U test or
Kruskal-Wallis analysis of variance, in case of more
than two groups. Post hoc pairwise comparisons were
performed with Dunn test if a difference between
the groups and the omnibus test were significant. We
conducted within-group comparisons with Friedman
two-way analysis of variance and post hoc pairwise
comparisons with Wilcoxon signed-rank test. Bon-
ferroni correction was applied for post hoc tests. If
outcome data were missing at follow-up, they were
replaced with subjects’ post-treatment results; if a
subject had neither post-treatment nor follow-up data,
they were excluded from the statistical analyses of
that variable. Effect sizes were assessed as estimates
of median differences and 95%-confidence inter-
vals (CI) were calculated with the Hodges-Lehmann
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method. Dichotomous variables were analyzed with
χ² test or Fisher’s exact test.
3. Results
3.1. Demographics and baseline characteristics
Altogether 50 subjects underwent all scheduled
outcome measurements. In Experiment 1, three sub-
jects missed DVA at post treatment and follow-up. In
Experiment 2, all subjects underwent all measure-
ments. In Experiment 3, one patient in the tDCS
group missed post-treatment HRP + all follow up
measurements, one subject in the tDCS group missed
follow-up HRP, and one subject in the sham group
missed all follow-up measurements (Fig. 1). Median
age of the subjects in Experiment 1 was 58 years
and 87.5% were men, whereas the numbers were
58 years and 72.2% in Experiment 2, and 68 years
and 71.4% in Experiment 3. Infarct affected the right
hemisphere in 58.3%, 55.6%, and 85.7%, respec-
tively. The groups in each experiment did not differ
in their demographics nor in their baseline measure-
ments (Table 1).
3.2. Effects of therapy
3.2.1. Experiment 1: rtACS vs. tDCS/rtACS vs.
sham
3.2.1.1 Primary outcomes: The median change of DA
from baseline was 0.2 percentage points (pp) (IQR
–1.3–0.3) in the rtACS group, 0.7 pp (IQR –0.2–1.2)
in the tDCS/rtACS group, and 1.3 pp (IQR –0.4–2.1)
in the sham group and did not differ between the
groups (H(2) = 3.10, p = 0.213) (Fig. 2, Table 2). The
median change of MS at post treatment in the ipsile-
sional eye was –0.1 dB (IQR –0.8–0.4) after rtACS,
0.3 dB (IQR –0.3–0.4) after tDCS/rtACS, and 0.7
dB (IQR 0.04–1.4) after sham and in the contrale-
sional eye –0.3 dB (IQR –1.0–0.2), 0.4 dB (IQR
–0.2–0.7), and 0.7 dB (IQR 0.1–1.2), respectively,
with a significant between-group difference in the
contralesional eye (H(2) = 6.26, p = 0.044). Pairwise
comparisons revealed that the difference was signif-
icant between the rtACS and sham group, resulting
in estimated median difference of –1.1 dB (95% CI,
–1.9– –0.2, Z = 2.48, adj. p = 0.040). MS improved in
the both eyes within the sham group (ipsilesional:
H(2) = 6.47, p = 0.039; contralesional: H(2) = 7.75,
p = 0.021), but pairwise comparisons showed a sig-
nificant difference only in the contralesional eye at
post treatment (Z = –2.75, adj. p = 0.018, estimated
median difference 0.7 dB [95% CI, 0.05–1.2]), but no
other significant within-group changes occurred. No
changes from baseline were detected at the 2-month
follow-up measurement.
3.2.1.2 Secondary outcomes: We observed some
improvements within the tDCS/rtACS group
(Table 2), whereby the absolute defect in the con-
tralesional eye diminished (H(2) = 9.36, p = 0.009);
pairwise comparisons showed a significant –1.5
pp (IQR –5.7–1.5) decrease at follow-up (Z = 2.63,
adj. p = 0.026, estimated median difference –3.0
pp [95% CI, –5.3– –0.8]). Reading speed increased
4.6 words/min (IQR –6.8–19.2) to post treatment
and 14.5 words/min (IQR 5.3–21.0) to follow-up
(H(2) = 10.52, p = 0.005), the latter of which reached
statistical significance (Z = –3.13, adj. p = 0.005,
estimated median difference 14 words/min [95% CI,
6.5–27.0]). Furthermore, average DVA improved
5.0 pp (IQR 1.9–9.7) to post treatment (H(2) = 7.36,
p = 0.025; post hoc Z = –2.50, adj. p = 0.037);
however, due to a small sample size the Hodges-
Lehman estimator had CI reaching both sides of
zero (5.3 pp, [95% CI, –5.0–10.6]). Finally, the
false positive responses in HRP decreased to post
treatment (H(2) = 7.16, p = 0.028; post hoc Z = 2.63,
adj. p = 0.026, estimated median difference –0.6
pp [95% CI, –1.0– –0.2]). However, none of these
changes were large enough to lead to significant
between-group differences.
Consistent with the MS results at post treatment,
the intact field of the contralesional eye increased 1.5
pp (IQR 0.4–5.7) in the sham group and decreased
–2.3 pp (IQR –5.7– –0.4) in the rtACS group, result-
ing in a significant between-group difference favoring
sham (H(2) = 8.63, p = 0.013; post hoc Z = 2.77, adj
p = 0.017, estimated median difference –6.1 pp [95%
CI, –9.1– –1.5]). In contrast, the between-group com-
parison of foveal sensitivity of the ipsilesional eye
showed opposite results: it decreased –0.5 dB (IQR
–1.0–0.0) in the sham group and increased 1.0 dB
(IQR 0.0–2.0) in the rtACS group, which yielded
a significant between-group difference at post treat-
ment (H(2) = 9.19, p = 0.010; post hoc Z = –2.86, adj.
p = 0.013, estimated median difference 2.0 dB [95%
CI, 1.0–2.0]) (Fig. 3).
3.2.2. Experiment 2: rtACS vs. sham
3.2.2.1 Primary outcomes: There was no difference
in the median DA change after the treatment between















Demographics and baseline measurements of the treatment groups in Experiments 1, 2, and 3
Experiment 1 Experiment 2 Experiment 3
All (n = 24) Sham (n = 8) ACS (n = 8) DCS/ACS (n = 8) p All (n = 18) Sham (n = 9) ACS (n = 9) p All (n = 14) Sham (n = 7) DCS (n = 7) p
Demographics
Age (y), median (IQR) 58 (51–66) 64 (59–67) 54 (51–66) 52 (45–64) 0.12 58 (36–67) 57 (36–69) 59 (34–66) 0.71 68 (60–73) 65 (57–68) 72 (67–81) 0.06
Male sex, n (%) 21 (87.5) 6 (75.0) 7 (87.5) 8 (100.0) 0.75 13 (72.2) 7 (77.8) 6 (66.7) 1.00 10 (71.4) 6 (85.7) 4 (57.1) 0.56
Infarct side, right, n (%) 14 (58.3) 5 (62.5) 5 (62.5) 4 (50.0) 1.00 10 (55.6) 5 (55.6) 5 (55.6) 1.00 12 (85.7) 7 (100.0) 5 (71.4) 0.46
HRP
DA (%), median (IQR) 55.9 (53.0–63.9) 57.0 (49.9–73.6) 54.0 (47.4–57.9) 58.0 (55.4–67.1) 0.31 74.0 (60.0–78.8) 76.0 (62.0–81.0) 72.0 (60.0–79.5) 0.85 70.0 (51.5–78.3) 55.7 (25.7–72.7) 74.3 (65.3–80.0) 0.16
RT (ms), median (IQR) 439 (401–477) 437 (392–523) 435 (397–471) 441 (405–470) 0.96 416 (380–476) 418 (395–521) 414 (370–447) 0.55 488 (429–550) 515 (436–589) 468 (405–537) 0.62
Absolute defect (%), median
(IQR)
38.6 (31.0–44.8) 35.5 (18.1–42.7) 44.7 (33.2–47.0) 37.4 (27.2–42.0) 0.21 24.8 (18.2–37.0) 23.2 (16.0–34.8) 26.8 (17.8–37.6) 0.73 – – – –
Relative defect (%), median
(IQR)
6.7 (3.8–15.1) 13.8 (3.1–2.8) 6.6 (3.1–14.6) 6.0 (3.9–8.9) 0.63 5.0 (3.4–7.0) 5.2 (3.2–9.9) 4.3 (3.3–6.7) 0.53 – – – –
Intact field (%), median (IQR) 52.6 (46.1–61.1) 52.8 (37.4–63.1) 49.6 (39.0–55.5) 55.3 (51.9–64.0) 0.30 71.1 (58.4–76.9) 72.5 (57.8–79.3) 69.8 (57.6–75.9) 0.80 – – – –
FA (%), median (IQR) 98 (96–99) 97 (96–100) 97 (96–100) 99 (96–99) 0.59 98 (95–100) 98 (92–100) 98 (95–100) 0.41 90 (65–97) 93 (66–97) 88 (61–97) 0.88
False positives (%), median
(IQR)
1.1 (0.4–2.1) 1.6 (0.5–4.1) 0.7 (0.4–1.5) 0.8 (0.4–3.0) 0.64 1.0 (0.8–2.0) 1.0 (0.5–2.5) 1.0 (0.5–1.5) 0.48 2.3 (1.5–4.3) 1.7 (1.0–3.0) 3.3 (1.7–5.3) 0.33
SAP
MS, ILE (dB), median (IQR) 12.6 (10.3–15.0) 12.7 (10.5–16.5) 11.5 (8.6–15.2) 12.6 (11.5–13.7) 0.59 17.7 (14.9–19.2) 17.7 (14.3–19.4) 17.7 (14.9–18.6) 0.75 17.5 (12.7–22.2) 19.1 (9.0–21.6) 15.9 (13.5–23.2) 0.54
MS, CLE (dB), median (IQR) 13.5 (11.6–15.7) 14.0 (11.9–16.6) 12.9 (8.9–16.2) 13.5 (11.9–14.9) 0.77 18.2 (16.3–20.3) 17.6 (15.1–20.8) 18.7 (16.1–19.8) 0.98 16.8 (12.8–22.0) 17.3 (10.5–22.3) 16.4 (13.5–21.9) 1.00
FS, ILE (dB), median (IQR) 26.0 (25.0–27.0) 26.0 (25.3–26.8) 25.5 (22.8–27.0) 27.5 (25.3–28.0) 0.18 32.0 (26.8–32.3) 32.0 (26.5–33.0) 31.0 (26.5–32.0) 0.32 35.0 (30.8–37.0) 35.0 (30.0–37.0) 35.0 (32.0–36.0) 0.81
FS, CLE (dB), median (IQR) 26.0 (24.0–27.0) 26.0 (22.3–26.0) 26.0 (23.3–27.8) 26.5 (24.3–27.8) 0.39 32.0 (29.5–33.0) 32.0 (29.0–32.5) 32.0 (30.0–33.0) 0.41 35.0 (31.3–36.3) 36.0 (29.0–38.0) 35.0 (33.0–36.0) 0.51
Absolute defect, ILE (%),
median (IQR)
34.1 (20.1–42.0) 31.1 (13.6–36.0) 40.9 (17.4–51.9) 34.1 (24.2–45.8) 0.37 – – – – – – – –
Absolute defect, CLE (%),
median (IQR)
28.8 (18.2–40.5) 22.7 (11.0–33.3) 37.1 (17.8–48.5) 33.3 (22.7–42.0) 0.10 – – – – – – – –
Relative defect, ILE (%),
median (IQR)
6.8 (3.0–13.3) 4.5 (1.9–13.6) 9.8 (3.4–11.7) 8.3 (3.0–17.0) 0.63 – – – – – – – –
Relative defect, CLE (%),
median (IQR)
6.1 (1.9–13.6) 11.4 (2.3–17.4) 6.1 (1.5–12.1) 4.5 (3.4–10.6) 0.57 – – – – – – – –
Intact field, ILE (%), median
(IQR)
59.1 (48.5–66.7) 66.7 (51.5–76.9) 50.8 (39.0–68.9) 55.3 (48.5–62.1) 0.20 – – – – – – – –
Intact field, CLE (%), median
(IQR)
59.9 (56.6–73.9) 65.9 (55.3–79.2) 58.3 (39.8–71.6) 59.1 (54.9–72.3) 0.61 – – – – – – – –
VA (decimal), median (IQR) 1.4 (0.8–1.4) 1.3 (0.8–1.4) 1.4 (0.8–1.4) 1.2 (0.8–1.4) 0.94 1.1 (0.8–1.4) 1.4 (0.9–1.4) 1.0 (0.8–1.4) 0.58 1.3 (1.0–1.3) 1.3 (1.0–1.3) 1.0 (1.0–1.3) 0.43
RS (words/min), median (IQR) 126 (93–150) 130 (84–148) 109 (82–183) 129 (120–145) 0.90 122 (98–137) 117 (78–138) 122 (101–134) 0.78 137 (104–160) 138 (58–156) 128 (120–171) 0.90
CS (logMAR), median (IQR) 1.76 (1.72–1.79) 1.74 (1.72–1.76) 1.76 (1.73–1.83) 1.76 (1.76–1.79) 0.23 – – – – 1.65 (1.50–1.65) 1.65 (1.50–1.65) 1.65 (1.50–1.65) 1.00
DVA (%), median (IQR) 75.0 (60.9–91.3) 76.3 (23.1–92.5) 75.0 (57.8–79.1) 81.9 (68.6–92.2) 0.82 – – – – – – – –
Between-group p values for continuous variables were calculated with Mann-Whitney U test or Kruskal-Wallis analysis of variance test in case of more than two groups and for dichotomous
variables with Fisher’s exact test. ACS, alternating current stimulation; DCS/ACS, combined cathodal direct current stimulation and alternating current stimulation; DCS, direct current stimulation;
HRP, high-resolution perimetry; DA, detection accuracy; RT, response time; FA, fixation accuracy; SAP, static automated perimetry; MS, mean sensitivity; FS, foveal sensitivity; ILE, ipsilesional















Results of Experiment 1: Sham vs. ACS vs. DCS/ACS
BASELINE – POST TREATMENT CHANGE BASELINE – FOLLOW-UP CHANGE Within-group p
Median (IQR) Between-group Median (IQR) Between-group
Sham (n = 8) ACS (n = 8) DCS/ACS (n = 8) Estimated p Sham (n = 8) ACS (n = 8) DCS/ACS (n = 8) Estimated p Sham ACS DCS/
median median ACS
difference difference
(95% CI) (95% CI)
HRP
DA (pp) 1.3 (–0.1–3.4) 0.2 (–1.3–0.3) 0.7 (–0.2–1.2) – 0.213 0.3 (–0.4–1.6) –0.4 (–1.3–0.01) 0.6 (–0.4–1.4) – 0.091 0.284 0.072 0.250
RT (ms) 11 (–5–42) 7 (–6–12) –3 (–21–10) – 0.271 11 (–2–58) 15 (–3–35) –3 (–15–6) – 0.107 0.417 0.223 0.284
Abs. defect (pp) –0.8 (–5.3–1.6) –0.3 (–1.3–1.3) 0.1 (–1.7–3.1) – 0.611 –0.1 (–0.9–4.2) 0.2 (–0.7–1.0) 0.0 (–1.3–1.5) – 0.911 0.657 0.657 0.875
Rel. defect (pp) 0.5 (–5.1–2.2) –0.7 (–0.7–1.5) 0.9 (–1.5–2.6) – 0.888 –0.5 (–8.7–1.8) –0.8 (–1.9–2.3) 0.9 (–2.1–1.7) – 0.676 0.657 0.419 0.687
Intact field (pp) 0.6 (–2.3–6.2) –0.6 (–1.8–1.4) 0.2 (–7.5–1.5) – 0.812 –0.2 (–1.5–8.2) 0.2 (–2.0–1.9) 0.5 (–3.9–2.1) – 0.920 1.000 1.000 0.485
FA (pp) –0.4 (–2.5–0.8) 0.4 (–0.5–2.9) 0.7 (–0.008–1.9) – 0.162 –0.4 (–6.9–1.9) 0.9 (–1.9–8.3) –0.6 (–1.1–1.3) – 0.564 0.725 0.508 0.356
False positives (pp) 0.02 (–0.4–1.4) –0.1 (–0.6–0.1) –0.6 (–1.2– –0.1) – 0.167 0.2 (–0.2–0.9) –0.3 (–0.9–0.1) –0.3 (–0.5–0.3) – 0.297 1.000 0.417 0.028j
SAP
MS, ILE (dB) 0.7 (0.04–1.4) –0.1 (–0.8–0.4) 0.3 (–0.3–0.4) – 0.060 0.3 (–0.05–0.7) 0.07 (–0.6–0.2) 0.5 (–0.5–1.2) – 0.454 0.039g 0.607 0.417
MS, CLE (dB) 0.7 (0.1–1.2) –0.3 (–1.0–0.2) 0.4 (–0.2–0.7) –1.1 (–1.9– –0.2)a 0.044d 0.3 (–0.3–0.6) –0.3 (–1.2–0.7) 0.7 (–0.3–1.1) – 0.213 0.021h 0.417 0.135
FS, ILE (dB) –0.5 (–1.0–0.0) 1.0 (0.0–2.0) 0.5 (0.0–1.8) 2.0 (1.0–2.0)a 0.010e 0.0 (–0.8–0.8) 0.5 (–0.8–1.0) 0.0 (0.0–0.8) – 0.781 0.102 0.084 0.483
FS, CLE (dB) 0.0 (–1.0–1.8) 0.0 (0.0–1.5) 0.5 (0.0–1.8) – 0.717 0.0 (–1.0–1.5) 0.0 (–0.8–2.5) 1.0 (0.0–1.8) – 0.565 0.692 0.646 0.108
Abs. defect, ILE (pp) –2.3 (–4.2–2.3) 0.0 (–1.5–6.1) 0.0 (–2.7–1.5) – 0.423 –0.8 (–3.0–2.3) 0.8 (–1.5–3.0) –3.0 (–5.7–4.9) – 0.591 0.289 0.898 0.670
Abs. defect, CLE (pp) 0.0 (–2.7–1.1) 0.8 (–2.7–1.5) –0.8 (–2.7–1.1) – 0.811 0.0 (0.0–1.1) 0.0 (–6.1–6.1) –1.5 (–5.7–1.5) – 0.069 0.638 0.798 0.009k
Rel. defect, ILE (pp) 0.0 (–2.7–3.0) 0.0 (–6.1–2.7) –0.8 (–2.7–1.5) – 0.855 0.0 (–4.5–2.7) –1.5 (–2.7–3.0) –1.5 (–4.2–1.1) – 0.763 0.961 0.687 0.725
Rel. defect, CLE (pp) –2.3 (–3.0– –0.4) 2.3 (–1.1–5.7) 0.0 (–1.5–3.0) – 0.071 0.0 (–3.0–0.0) 2.3 (0.0–9.1) 2.3 (0.0–5.7) – 0.104 0.154 0.140 0.096
Intact field, ILE (pp) 2.3 (–2.3–6.4) –0.8 (–3.0–2.7) 0.8 (–1.1–2.7) – 0.464 0.0 (–2.3–2.3) –0.8 (–2.7–2.7) 3.0 (–0.8–4.6) – 0.205 0.495 0.779 0.177
Intact field, CLE (pp) 1.5 (0.4–5.7) –2.3 (–5.7– –0.4) 1.5 (–0.8–2.7) –6.1 (–9.1– –1.5)a 0.013f 0.0 (–2.3–1.5) –1.5 (–6.4–1.1) 1.5 (0.0–1.5) – 0.342 0.080 0.039i 0.102
VA (decimal) 0.0 (–0.4–0.0) 0.0 (–0.08–0.0) 0.0 (0.0–0.2) – 0.561 –0.1 (–0.3–0.0) 0.0 (0.0–0.3) 0.1 (0.0–0.2) – 0.145 0.268 0.174 0.291
RS (w/min) 4.2 (–7.5–9.3) 6.5 (–7.8–14.6) 4.6 (–6.8–19.2) – 0.850 6.5 (–4.5–16.0) 6.0 (–5.3–22.3) 14.5 (5.3–21.0) – 0.382 0.284 0.792 0.005l
CS (logMAR) 0.04 (0.00–0.07) 0.00 (0.00–0.04) 0.00 (–0.07–0.05) – 0.408 0.00 (0.00–0.00) 0.02 (–0.03–0.04) 0.00 (–0.04–0.09) – 0.796 0.196 0.554 0.568
DVA (pp) 2.5 (–1.6–9.1)b 0.0 (–1.3–11.3)c 5.0 (1.9–9.7) – 0.719 –5.0 (–14.4–2.2)b 1.3 (–10.0–3.8)c 0.6 (0.0–7.5) – 0.356 0.385 0.772 0.025m
P values were calculated with Kruskal-Wallis test with post hoc pairwise comparison with Dunn test (between groups) and Friedman two-way analysis of variance test with post hoc pairwise
comparison with Wilcoxon signed-rank test (within groups). Estimated median differences between groups and 95%-confidence intervals (CI) were calculated with the Hodges-Lehmann method
for variables and treatment arms with significant between-group difference after pairwise comparison. Significant p values are bolded. ACS, alternating current stimulation; DCS/ACS, combined
cathodal direct current stimulation / alternating current stimulation; HRP, high-resolution perimetry; DA, detection accuracy; RT, response time; FA, fixation accuracy; SAP, static automated
perimetry; MS, mean sensitivity; FS, foveal sensitivity; ILE, ipsilesional eye; CLE, contralesional eye; VA, visual acuity; RS, reading speed; CS, contrast sensitivity; DVA, dynamic visual acuity;
aCounted for ACS vs. sham, negative values favoring sham and positive ACS; bn = 6, cn = 7; dpost hoc p for Sham-ACS 0.040; epost hoc p for ACS-Sham 0.013; f post hoc p for Sham-ACS 0.017;
gpost hoc p n.s; hpost hoc p for baseline vs. post treatment 0.018; ipost hoc p n.s.; jpost hoc p for baseline vs. post treatment 0.026; kpost hoc p for baseline vs. follow-up 0.026; lpost hoc p for
baseline vs. follow-up 0.005; mpost hoc p for baseline vs. post treatment 0.037.
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pp [–0.5–1.0], U = 37.5, p = 0.823), nor in the MS
of the ipsilesional (rtACS 0.3 dB [IQR –0.4–0.7],
sham 0.5 dB [IQR –0.2–0.9], U = 31.5, p = 0.504)
or contralesional eye (rtACS 0.7 dB [IQR –0.9–1.4],
sham 0.3 dB [IQR 0.0–0.7], U = 35.0, p = 0.621). The
results remained neutral at the 2-month follow-up
(Table 3).
Fig. 3. Changes of foveal sensitivity of the ipsilesional eye
from baseline in Experiment 1. Median changes from baseline,
95%-CIs, and between-group p values, calculated with Kruskal-
Wallis analysis of variance test are given. ACS, alternating
current stimulation; DCS/ACS, combined direct current stimu-
lation/alternating current stimulation; FS, foveal sensitivity ILE,
ipsilesional eye. ∗ACS vs. Sham, calculated from post hoc pairwise
comparison.
3.2.2.2 Secondary outcomes: No significant changes
in any of the secondary outcomes were detected
(Table 3).
3.2.3. Experiment 3: tDCS vs. sham
3.2.3.1 Primary outcomes: MS of the contralesional
eye increased 0.8 dB (IQR –0.2–2.1) in the tDCS
group and decreased –0.7 dB (IQR –1.0–0.5) in
the sham group between baseline and post treat-
ment, resulting in a trend in between-group difference
(U = 40.0, p = 0.053, estimated median difference 1.5
dB [95% CI, 0.02–5.2]) (Fig. 2, Table 4). After
the 2-month follow-up, MS of the tDCS group had
increased 1.3 dB (IQR 0.5–3.3) and that of the sham
group decreased –0.5 dB (IQR –1.7–0.3) from base-
line (U = 43.0, p = 0.017, estimated median difference
2.2 dB [95% CI, 0.6–5.0]). However, the within-
group changes were non-significant. No significant
between-group changes were seen after the treatment
in MS of the ipsilesional eye (tDCS 0.2 dB [IQR
–0.2–1.0], sham 0.2 dB [IQR –1.0–0.2], U = 30.0,
p = 0.535) or in DA (tDCS 0.0 pp [IQR –7.3–4.0],
sham 3.3 pp [IQR –0.7–4.7], U = 13.0, p = 0.295).
3.2.3.2 Secondary outcomes: All secondary out-
come variables were neutral in both treatment arms
(Table 4).
Table 3
Results of Experiment 2: Sham vs. ACS
BASELINE – POST TREATMENT CHANGE BASELINE – FOLLOW-UP CHANGE Within-
group p
Median (IQR) Between-group Median (IQR) Between-group
Sham (n = 9) ACS (n = 9) Estimated p Sham (n = 9) ACS (n = 9) Estimated p Sham ACS
median median
difference difference
(95% CI) (95% CI)
HRP
DA (pp) 0.0 (–0.5–1.0) 1.0 (–1.0–1.5) 0.0 (–1.0–1.0) 0.823 1.0 (–1.0–2.0) 0.0 (–0.5–1.0) 0.0 (–2.0–1.0) 0.636 0.497 0.453
RT (ms) –33 (–39– –15) –11 (–29–3) 16 (–5–35) 0.142 –20 (–50–7) –12 (–36–28) 13 (–23–49) 0.423 0.097 0.368
Abs. defect (pp) –0.3 (–0.9–1.0) –0.5 (–3.0–0.6) –0.7 (–3.0–0.9) 0.503 –0.7 (–1.7–0.9) –0.5 (–1.3–0.3) 0.0 (–1.6–1.6) 0.914 0.347 0.490
Rel. defect (pp) 0.0 (–3.0–0.7) –0.7 (–1.5–1.7) 0.2 (–1.6–2.5) 0.914 0.2 (–3.3–1.5) –0.5 (–0.7–0.8) 0.0 (–2.0–3.2) 0.879 0.625 0.773
Intact field (pp) 0.2 (0.1–1.5) 1.4 (0.8–1.9) 0.9 (–0.5–1.6) 0.197 1.4 (0.0–2.1) 0.7 (–1.3–1.4) –0.7 (–3.0–0.7) 0.267 0.065 0.092
FA (pp) 0.0 (–1.0–3.5) –1.0 (–1.0–0.5) 0.0 (–4.0–1.0) 0.507 1.0 (–0.5–3.5) 0.0 (–3.5–1.5) –1.0 (–8.0–1.0) 0.193 0.284 0.422
False positives (pp) 0.0 (–1.0–0.0) 0.0 (–0.5–0.5) 0.0 (0.0–1.0) 0.440 0.0 (0.0–0.0) 0.0 (–1.0–0.0) 0.0 (–1.0–0.0) 0.361 0.305 0.368
SAP
MS, ILE (dB) 0.5 (–0.2–0.9) 0.3 (–0.4–0.7) –0.3 (–1.1–0.4) 0.504 0.3 (–0.6–1.2) 0.3 (–0.5–0.8) –0.1 (–1.0–0.9) 0.845 0.175 0.641
MS, CLE (dB) 0.3 (0.0–0.7) 0.7 (–0.9–1.4) 0.3 (–1.3–1.1) 0.621 0.4 (–0.7–0.7) 0.5 (–1.2–1.0) 0.0 (–1.5–1.4) 0.949 0.368 0.641
FS, ILE (dB) –1.0 (–1.5–6.0) –1.0 (–3.0–3.0) –1.0 (–7.0–2.0) 0.471 0.0 (–1.5–5.0) 0.0 (–3.5–1.0) –1.0 (–6.0–2.0) 0.501 0.889 0.809
FS, CLE (dB) –1.0 (–2.0–1.5) 0.0 (–2.0–3.0) 0.0 (–4.0–4.0) 0.876 0.0 (–1.0–3.5) –1.0 (–5.0–1.0) –2.0 (–7.0–1.0) 0.167 0.331 0.430
VA (decimal) 0.0 (–0.2–0.0) 0.0 (0.0–0.2) 11.1 (0.0–25.0) 0.052 0.0 (–0.1–0.1) 0.0 (0.0–0.3) 0.0 (–5.6–28.6) 0.320 0.179 0.161
RS (w/min) 2.8 (–9.0–6.8) 4.5 (–3.8–9.1) 4.6 (–6.0–13.4) 0.489 2.2 (–7.0–11.6) 4.6 (0.5–14.8) 2.5 (–7.5–14.4) 0.328 0.641 0.097
Estimated median differences between groups and 95%-confidence intervals (CI) were calculated with the Hodges-Lehmann method, negative
values favoring sham and positive ACS. P values were calculated with Mann-Whitney U test (between groups) and Friedman two-way analysis
of variance test with post hoc pairwise comparison with Wilcoxon signed-rank test (within groups). ACS, alternating current stimulation;
HRP, high-resolution perimetry; DA, detection accuracy; RT, response time; FA, fixation accuracy; SAP, static automated perimetry; MS,
mean sensitivity; FS, foveal sensitivity; ILE, ipsilesional eye; CLE, contralesional eye; VA, visual acuity; RS, reading speed.
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Table 4
Results of Experiment 3: Sham vs. DCS
BASELINE – POST TREATMENT CHANGE BASELINE – FOLLOW-UP CHANGE Within-
group p
Median (IQR) Between-group Median (IQR) Between-group
Sham (n = 7) DCS (n = 7) Estimated p Sham (n = 7)a ACS (n = 7)a Estimated p Sham DCS
median median
difference difference
(95% CI) (95% CI)
HRP
DA (pp) 3.3 (–0.7–4.7) 0.0 (–7.3–4.0)b –2.7 (–11.0–3.7) 0.295 1.3 (–8.0–4.0) 3.1 (–1.1–8.6)b 3.3 (–4.0–11.7) 0.558 0.459 0.070
RT (ms) –17 (–39–16) –11 (–22–1)b 7 (–34–49) 0.731 –59 (–129– –54) –34 (–62– –1)b 46 (–25–106) 0.181 0.066 0.084
FA (pp) 4.0 (–0.3–16.7) 0.0 (–7.3–9.1)b –5.3 (–24.7–45.2) 0.445 2.7 (–2.7–30.0) 2.3 (–3.0–12.2)b –0.5 (–27.7–25.0) 0.731 0.383 0.607
False positives
(pp)
–0.3 (–1.0–0.0) 0.2 (–0.8–0.7)b 0.7 (–1.3–1.7) 0.346 –1.0 (–1.3–0.3) –0.7 (–1.6–0.7)b 0.3 (–2.3–1.7) 0.749 0.236 0.385
SAP
MS, ILE (dB) 0.2 (–1.0–0.2) 0.2 (–0.2–1.0) 0.5 (–0.5–2.2) 0.535 0.5 (–1.1–0.9) 0.1 (–0.7–2.0) 0.9 (–1.3–2.8) 0.710 0.368 0.459
MS, CLE (dB) –0.7 (–1.0–0.5) 0.8 (–0.2–2.1) 1.5 (0.02–5.2) 0.053 –0.5 (–1.7–0.3) 1.3 (0.5–3.3) 2.2 (0.6–5.0) 0.017 0.317 0.163
FS, ILE (dB) 1.0 (0.0–3.0) –1.0 (–2.0–3.0) –2.0 (–4.0–2.0) 0.318 1.5 (–0.3–3.3) –0.5 (–2.3–0.5) –2.0 (–4.0–0.0) 0.107 0.097 0.887
FS, CLE (dB) 1.0 (–1.0–2.0) 0.0 (–2.0–1.0) –1.0 (–3.0–1.0) 0.438 0.0 (–2.0–3.3) 0.0 (–0.5–2.3) 0.0 (–3.0–3.0) 1.000 0.747 0.662
VA (decimal) 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.0 (0.0–0.0) 1.000 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.0 (0.0–0.0) 1.000 0.368 0.717
RS (w/min) 3.5 (–2.0–15.5) 3.0 (–2.5–8.5) –1.5 (–15.0–6.5) 0.710 0.5 (–10.0–28.5) 5.5 (–6.0–7.0) –0.5 (–23.5–15.5) 1.000 0.459 0.513
CS (logMAR) 0.0 (0.0–0.0) 0.0 (–0.2–0.0) 0.0 (–0.2–0.0) 0.514 0.0 (0.0–0.0) 0.0 (–0.2–0.0) 0.0 (–0.2–0.0) 0.486 0.717 0.368
Estimated median differences between groups and 95%-confidence intervals (CI) were calculated with the Hodges-Lehmann method, negative
values favoring sham and positive DCS. P values were calculated with and Mann-Whitney U test (between groups) and Friedman two-way
analysis of variance test with post hoc pairwise comparison with Wilcoxon signed-rank test (within groups). Significant p values are bolded.
DCS, direct current stimulation; HRP, high-resolution perimetry; DA, detection accuracy; RT, response time; FA, fixation accuracy; SAP,
static automated perimetry; MS, mean sensitivity; FS, foveal sensitivity; ILE, ipsilesional eye; CLE, contralesional eye; VA, visual acuity; RS,
reading speed; CS, contrast sensitivity. aResults of one subject with missing outcome data at follow-up was replaced with their post-treatment
results, bn = 6.
3.3. Safety
No serious adverse events occurred. In Experi-
ment 1, the most common adverse effect was mild
skin irritation under stimulation electrodes during the
treatment (rtACS: n = 3, tDCS/rtACS: n = 1, sham:
n = 3). In addition, the rtACS group experienced
metallic taste (n = 2) and mild discomfort during
stimulation (n = 1); the tDCS/rtACS group reported
metallic taste during the stimulation (n = 1), and
paroxysmal phosphene-like visual phenomena (n = 1)
and tiredness between sessions (n = 1); and the sham
group had metallic taste (n = 1) and other skin sensa-
tions (n = 1) during the stimulation. No difference in
the frequency of any of the reported adverse effects,
nor in their composite number per subject occurred
between the different modalities (rtACS: median 1
per subject [IQR 0–2.5], tDCS/rtACS: median 0 per
subject [IQR 0–1.5], sham: median 0.5 [IQR 0–1.8],
p = 0.431).
In Experiment 2, the subjects reported mild skin
irritation under the stimulation electrodes during
the treatment (rtACS: n = 8, sham: n = 7), metallic
taste (rtACS: n = 2, sham: n = 3), other skin sensa-
tions (rtACS: n = 3, sham: n = 4), chills (rtACS: n = 3,
sham: n = 1), myokymia (rtACS: n = 1, sham: n = 1),
dizziness (rtACS: n = 1), and transient discomfort
during the intervention (rtACS: n = 1), as well as
tiredness (rtACS: n = 2, sham: n = 4), paroxysmal
phosphene-like visual phenomena (rtACS: n = 3,
sham: n = 3), mild headache (rtACS: n = 3, sham:
n = 1), sleeping difficulties (sham: n = 1), and lack
of concentration (sham: n = 1) between the sessions.
Consistent with Experiment 1, no difference was
observed in the number of individual adverse effect,
nor in their composite number per subject (rtACS:
median 3.0 per subject [IQR 2.0–5.5], sham: median
4.0 per subject [IQR 1.5–5.0], p = 0.194). In Experi-
ment 3, all subjects reported mild skin sensations.
4. Discussion
To the best of our knowledge, this is the first ran-
domized, sham-controlled trial exploring different
NIBS modalities for the rehabilitation of hemianopia
after occipital stroke, including a tDCS/rtACS reg-
imen. The study did not demonstrate efficacy of
the NIBS methods on the primary endpoints in two
experiments (1 and 2). However, the tDCS-alone
modality (Experiment 3) led to some improvement
in monocular vision compared to sham. Addition-
ally, the combined tDCS/rtACS reduced the absolute
field defect, increased dynamic vision, and improved
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reading from baseline, but did not differ significantly
from the sham group. rtACS was mostly ineffective
and, regarding some outcomes, even inferior to sham.
The stimulation was well tolerated with the number of
adverse events comparable to previous reports (Antal
et al., 2017), providing further evidence for the safe
application of NIBS.
The effects of NIBS, especially rtACS, were
smaller than expected and not comparable to changes
reported after optic nerve damage (Gall et al., 2016).
Possible causes for the low efficacy are several. First,
compared to people with optic nerve injury, hemi-
anopic patients tend to have smaller areas of residual
vision (relative defects with partial vision), i.e. areas,
where they see some of the presented stimuli, but not
all (Sabel et al., 2011). As the areas of residual vision
are thought to possess the greatest recovery poten-
tial (Sabel et al., 2011), our results may reflect their
small size at baseline. Another explanation may lie
in the central origin of the damage. If the reorganiz-
ing brain is a basis for vision recovery, damage to the
brain might leave a smaller recovery potential. This
is supported by the overall low efficacy of restorative
attempts in stroke-related VFD (Pollock et al., 2019).
Moreover, the few previous successful rehabilitation
studies have combined NIBS with visual training
(Alber et al., 2017; Plow et al., 2011; Plow et al.,
2012), which may be prerequisite for vision restora-
tion in post-chiasmal visual impairment. Likewise,
the stimulation might be effective only if applied in
the acute or subacute phase, when the plasticity after
stroke is at its greatest (Murphy & Corbett, 2009).
Most importantly, the current flow after rtACS may
not be optimal for vision rehabilitation after central
damage. It travels mostly through the frontal cortex
and the eye, moving along the optic nerve, towards the
brainstem (Gall et al., 2016). It has been hypothesized
to elicit synchronous activation of retinal ganglion
cells when the retinae and optic nerves are stimulated
(Foik et al., 2015; Gall et al., 2016); however, little,
if any, current reaches the visual cortex. This might
explain why rtACS treatment alone is beneficial for
patients with optic nerve damage (Gall et al., 2016)
but not for those with occipital lesions. Our results are
supported by a recent study that showed that occipital,
but not transorbital, ACS modulated occipital oscil-
lations and affected visual detection ability (Herring
et al., 2019). Thus, the former might be worth fur-
ther studying in vision rehabilitation after occipital
stroke.
Interestingly, the sham group demonstrated small
improvements in some of the monocular visual
variables compared to the rtACS treatment. This
implies that minimal stimulation used as sham might
actually have beneficial effects on the visual system.
Therefore, it is a continuing challenge in the future
trials to create a sham protocol devoid of the minimal
stimulation effect, yet maintain the blinding.
Although the overall NIBS effects were not favor-
able, our exploration yielded some positive signals
after tDCS alone. We found a statistically significant
2.2-dB difference in MS of the contralesional eye
compared to the sham group at follow-up and a trend
towards improvement at post treatment. Although the
clinical improvement was modest, it was in line with
the few pilot studies on combined tDCS and visual
training that have reported vision restoration in hemi-
anopia (Alber et al., 2017; Plow et al., 2011; Plow et
al., 2012). Moreover, the variability in response to
the stimulation was notable, as indicated by wide CIs
(Fig. 2), suggesting that some patients may benefit
from tDCS, whereas others do not. Unfortunately, the
small sample size of the experiment did not allow us
to study factors influencing the treatment response.
Another modality producing a few cautiously
positive findings was the combined tDCS/rtACS. Dif-
ferent stimulation protocols can interact when applied
successively under certain timing conditions, produc-
ing either enhanced or opposing effects (Huang et
al., 1992; Lang et al., 2004). In the present study,
cathodal tDCS may have induced a priming effect
on rtACS, leading to a different impact than rtACS
alone. Alternatively, tDCS might have neutralized or
counteracted ACS, because the latter exerts weaker
effects on neural activity (Antal et al., 2008). Con-
sidering the results of tDCS and rtACS alone and
the lack of direct comparison of the combined pro-
tocol with the former, we cannot conclude, whether
tDCS/rtACS inflicts any additional benefit over tDCS
alone.
The effects of tDCS and tDCS/rtACS were de-
tected mainly in the contralesional eye, which can-
not be easily explained by the gross anatomy of the
primary visual pathway. In normal vision, the lateral
hemifield supports more peripheral and less central
vision, which have different anatomical inputs: the
latter is driven predominantly by the retino-geniculate
pathway, whereas the former also depends on the
extrastriate pathway, which supports movement per-
ception and controls eye movements. It is proposed to
be the main mechanism of “blindsight” (Poppel et al.,
1973; Weiskrantz et al., 1974), where patients with
lesioned primary visual cortex can perform detection
tasks without being aware of the stimuli. Of note,
S. Räty et al. / Non-invasive electrical brain stimulation for vision restoration after stroke 233
training “blindsight” is one way to improve vision
in patients with hemianopia (Raninen et al., 2007;
Sahraie et al., 2006). Thus, vision restoration ther-
apy after stroke might be of greater benefit to the
extrastriate pathway than to the region of primary
damage, explaining the improvement in the contrale-
sional eye and increased dynamic vision. If true, the
response variability to NIBS might depend in part on
the extent of extrastriate damage. Nevertheless, our
results should be viewed with caution, because the
groups were small and no systematic changes in both
within- and between-group results were observed.
4.1. Strengths and limitations
The strength of our study was its randomized,
sham-controlled, double-blinded design and the ex-
ploration of several different NIBS modalities in reha-
bilitation of post-chiasmal vision damage. We used
comprehensive examinations of visual function and
several methods to control for fixation. Only little
patient dropout was experienced, and all subjects
were treated according to their allocation.
However, our study possessed several limitations.
Given its exploratory character and the small sam-
ple size, our results cannot be generalized. The target
sample size defined in the protocol was not reached
due to technical and funding issues; yet, our study is
still among the largest using NIBS in vision rehabil-
itation. Although the variations of the experimental
protocol, randomization, and examination methods
at the centers enabled experimenting with differ-
ent setups, they did not allow a direct comparison
between the modalities used in different experiments.
Finally, the number of examinations—although
acceptable in an exploratory setup—raises the ques-
tion of multiple comparisons and must be addressed
in the future confirmatory studies.
5. Conclusions
Despite the mostly neutral results, some positive
findings of the tDCS and tDCS/rtACS modalities and
the good safety profile of NIBS encourage further
research. This, however, requires increased knowl-
edge of the underlying mechanisms to establish the
optimal treatment paradigm. rtACS, however, does
not seem to provide much efficacy in rehabilitation of
vision after stroke. There are open questions, which
include optimizing the current flow with respect to
the underlying EEG rhythms, stimulating both the
striate and extrastriate retinofugal pathway, and find-
ing a sham condition without the minimal stimulation
effect. If these goals are achieved, we believe that a
larger-sample trial with a tDCS-based method, pos-
sible in combination with visual training, is justified.
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234 S. Räty et al. / Non-invasive electrical brain stimulation for vision restoration after stroke
Antal, A., Boros, K., Poreisz, C., Chaieb, L., Terney, D., & Paulus,
W. (2008). Comparatively weak after-effects of transcranial
alternating current stimulation (tACS) on cortical excitability
in humans. Brain Stimulation, 1(2), 97-105.
Bola, M., Gall, C., Moewes, C., Fedorov, A., Hinrichs, H., &
Sabel, B. A. (2014). Brain functional connectivity network
breakdown and restoration in blindness. Neurology, 83(6),
542-551.
Dougherty, B. E., Flom, R. E., & Bullimore, M. A. (2005). An eval-
uation of the MARS letter contrast sensitivity test. Optometry
and Vision Science, 82(11), 970-975.
Foik, A. T., Kublik, E., Sergeeva, E. G., Tatlisumak, T., Rossini, P.
M., Sabel, B. A., & Waleszczyk, W. J. (2015). Retinal origin
of electrically evoked potentials in response to transcorneal
alternating current stimulation in the rat. Investigative Oph-
thalmology & Visual Science, 56(3), 1711-1718.
Gall, C., Franke, G. H., & Sabel, B. A. (2010). Vision-related
quality of life in first stroke patients with homonymous visual
field defects. Health & Quality of Life Outcomes, 8, 33.
Gall, C., Schmidt, S., Schittkowski, M. P., Antal, A., Ambrus,
G. G., Paulus, W.,... Sabel, B. A. (2016). Alternating current
stimulation for vision restoration after optic nerve damage: A
randomized clinical trial. PloS One, 11(6), e0156134.
Gall, C., Silvennoinen, K., Granata, G., de Rossi, F., Vecchio,
F., Brosel, D.,... Sabel, B. A. (2015). Non-invasive electric
current stimulation for restoration of vision after unilateral
occipital stroke. Contemporary Clinical Trials, 43, 231-236.
Gray, C. S., French, J. M., Bates, D., Cartlidge, N. E., Venables, G.
S., & James, O. F. (1989). Recovery of visual fields in acute
stroke: Homonymous hemianopia associated with adverse
prognosis. Age & Ageing, 18(6), 419-421.
Halko, M. A., Datta, A., Plow, E. B., Scaturro, J., Bikson, M.,
& Merabet, L. B. (2011). Neuroplastic changes following
rehabilitative training correlate with regional electrical field
induced with tDCS. Neuroimage, 57(3), 885-891.
Herring, J. D., Esterer, S., Marshall, T. R., Jensen, O., & Bergmann,
T. O. (2019). Low-frequency alternating current stimula-
tion rhythmically suppresses gamma-band oscillations and
impairs perceptual performance. Neuroimage, 184, 440-449.
Huang, Y. Y., Colino, A., Selig, D. K., & Malenka, R. C. (1992).
The influence of prior synaptic activity on the induction of
long-term potentiation. Science, 255(5045), 730-733.
Kanai, R., Chaieb, L., Antal, A., Walsh, V., & Paulus, W. (2008).
Frequency-dependent electrical stimulation of the visual cor-
tex. Current Biology, 18(23), 1839-1843.
Kasten, E., Wust, S., Behrens-Baumann, W., & Sabel, B. A. (1998).
Computer-based training for the treatment of partial blind-
ness. Nature Medicine, 4(9), 1083-1087.
Lang, N., Siebner, H. R., Ernst, D., Nitsche, M. A., Paulus, W.,
Lemon, R. N., & Rothwell, J. C. (2004). Preconditioning with
transcranial direct current stimulation sensitizes the motor
cortex to rapid-rate transcranial magnetic stimulation and
controls the direction of after-effects. Biological Psychiatry,
56(9), 634-639.
Larcombe, S. J., Kulyomina, Y., Antonova, N., Ajina, S., Stagg, C.
J., Clatworthy, P. L., & Bridge, H. (2018). Visual training in
hemianopia alters neural activity in the absence of behavioural
improvement: A pilot study. Ophthalmic & Physiological
Optics, 38(5), 538-549.
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Koch, C., & Buzsáki, G. (2010). Transcranial electric stimula-
tion entrains cortical neuronal populations in rats. The Journal
of Neuroscience, 30(34), 11476-11485.
Plow, E. B., Obretenova, S. N., Fregni, F., Pascual-Leone, A., &
Merabet, L. B. (2012). Comparison of visual field training
for hemianopia with active versus sham transcranial direct
cortical stimulation. Neurorehabilitation and Neural Repair,
26(6), 616-626.
Plow, E. B., Obretenova, S. N., Halko, M. A., Kenkel, S., Jackson,
M. L., Pascual-Leone, A., & Merabet, L. B. (2011). Com-
bining visual rehabilitative training and noninvasive brain
stimulation to enhance visual function in patients with hemi-
anopia: A comparative case study. PM & R, 3(9), 825-835.
Pollock, A., Hazelton, C., Rowe, F. J., Jonuscheit, S., Kernohan, A.,
Angilley, J.,... Campbell, P. (2019). Interventions for visual
field defects in people with stroke. Cochrane Database of
Systematic Reviews, (5).
Poppel, E., Held, R., & Frost, D. (1973). Leter: Residual visual
function after brain wounds involving the central visual path-
ways in man. Nature, 243(5405), 295-296.
Raninen, A., Vanni, S., Hyvarinen, L., & Nasanen, R. (2007). Tem-
poral sensitivity in a hemianopic visual field can be improved
by long-term training using flicker stimulation. Journal of
Neurology, Neurosurgery & Psychiatry, 78(1), 66-73.
Rossini, P. M., Calautti, C., Pauri, F., & Baron, J. (2003).
Post-stroke plastic reorganisation in the adult brain. Lancet
Neurology, 2(8), 493-502.
Rowe, F. J., Hepworth, L. R., Howard, C., Hanna, K. L., Cheyne,
C. P., & Currie, J. (2019). High incidence and prevalence of
visual problems after acute stroke: An epidemiology study
with implications for service delivery. PloS One, 14(3),
e0213035.
Sabel, B. A., Henrich-Noack, P., Fedorov, A., & Gall, C. (2011).
Vision restoration after brain and retina damage: The “residual
vision activation theory”. Progress in Brain Research, 192,
199-262.
Sabel, B. A., Thut, G., Haueisen, J., Henrich-Noack, P., Herrmann,
C. S., Hunold, A.,... Antal, A. (2020). Vision modulation,
plasticity and restoration using non-invasive brain stimula-
tion - an IFCN-sponsored review. Clinical Neurophysiology,
131(4), 887-911.
Sahraie, A., Trevethan, C. T., MacLeod, M. J., Murray, A. D.,
Olson, J. A., & Weiskrantz, L. (2006). Increased sensitiv-
ity after repeated stimulation of residual spatial channels in
blindsight. Proceedings of the National Academy of Sciences
of the United States of America, 103(40), 14971-14976.
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